维生素D与多囊卵巢综合征相关性研究进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (681 KB) HTML (24 KB)
输出: BibTeX | EndNote (RIS)

摘要多囊卵巢综合征(PCOS)是青春期及育龄妇女的常见疾病,目前关于PCOS的确切病因与发病机制尚不清楚。但随着研究的深入,研究表明PCOS患者普遍存在维生素D的缺乏,维生素D的缺乏与PCOS患者的内分泌及代谢紊乱相关,适当补充维生素D可能有助于改善PCOS患者的临床相关症状,并提高其妊娠率。本文就目前维生素D与PCOS的相关研究展开综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王红梅
	王芳

关键词 ：多囊卵巢综合征, 维生素D, 胰岛素抵抗

收稿日期: 2018-04-02

通讯作者: 王芳(wangfangkx@163.com)

引用本文:

王红梅, 王芳. 维生素D与多囊卵巢综合征相关性研究进展[J]. 中国生育健康杂志, 2019, 30(3): 291-293.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2019/V30/I3/291

1 Carmona-Ruiz IO,Saucedo-de LE,Moraga-Sánchez MR,et al.Polycystic ovary syndrome:is there a rise in the prevalence?.Ginecol Obstet Mex,2015,83:750-759.
2 Dargham SR,Ahmed L,Kilpatrick ES,et al.The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population.PloS one,2017,12:e0181467.
3 Bozdag G,Mumusoglu S,Zengin D,et al.The prevalence and phenotypic features of polycystic ovary syndrome:a systematic review and meta-analysis.Hum Reprod,2016,31:2841-55.
4 贾新转,魏兰,王咏梅.PCOS患者卵泡液维生素D水平与IVF周期结局相关性分析.现代预防医学,2015,42:1904-1906.
5 夏维波.维生素 D 及其类似物临床应用共识.协和医学杂志,2018,9:127-143.
6 Pludowski P,Holick MF,Pilz S,et al.Vitamin D effects on musculoskeletal health,immunity,autoimmunity,cardiovascular disease,cancer,fertility,pregnancy,dementia and mortality-a review of recent evidence.Autoimmun Rev,2013,12:976-989.
7 Thomson RL,Spedding S,Buckley JD.Vitamin D in the aetiology and management of polycystic ovary syndrome.Clin Endocrinol(Oxf),2012,77:343-350.
8 Ngo DTM,Chan WP,Rajendran S,et al.Determinants of insulin responsiveness in young women:impact of polycystic ovarian syndrome,nitric oxide,and vitamin D.Nitric oxide,2011,25:326-330.
9 Trummer C,Pilz S,Schwetz V,et al.Vitamin D,PCOS and androgens in men:a systematic review.Endocr Connect,2018,7:R95-R113.
10 Mishra S,Das AK,Das S.Hypovitaminosis D and associated cardiometabolic risk in women with PCOS.J Clin Diagn Res,2016,10:BC01.
11 Jamilian M,Foroozanfard F,Rahmani E,et al.Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.Nutrients,2017,9:1280.
12 Oliveira RMS,Novaes JF,Azeredo LM,et al.Association of vitamin D insufficiency with adiposity and metabolic disorders in Brazilian adolescents.Public Health Nutr,2014,17:787-794.
13 Du H,Daftary GS,Lalwani SI,et al.Direct regulation of HOXA10 by 1,25-(OH) 2D3 in human myelomonocytic cells and human endometrial stromal cells.Mol Endocrinol 2005,19:2222-2233.
14 叶碧绿.维生素D与多囊卵巢综合征相关性的研究进展.生殖医学杂志,2014,23:431-434.
15 孟婕,王迪,艾继辉,等.血清25羟基维生素D水平与多囊卵巢综合征的关联研究.中国妇幼保健,2013,28:1333-1335.
16 Manson JAE,Bassuk SS.Vitamin D research and clinical practice:at a crossroads.JAMA-J AM MED ASSOC,2015,313:1311-1312.
17 Kimball SM,Mirhosseini N,Holick MF.Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a community setting.Dermatoendocrinol,2017,9:e1300213.
18 Muscogiuri G,Altieri B,de Angelis C,et al.Shedding new light on female fertility:The role of vitamin D.Rev Endocr Metab Dis,2017,18:273-283.
19 Pilz S,Kienreich K,Tomaschitz A,et al.Vitamin D and cancer mortality:systematic review of prospective epidemiological studies.Anti-Cancer Agent Me,2013,13:107-117.
20 Irani M,Minkoff H,Seifer DB,et al.Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.J Clin Endocr Metab,2014,99:E886-E890.
21 Lerchbaum E,Rabe T.Vitamin D and female fertility.Curr Opin Obstet Gyn,2014,26:145-150.
22 Kerchner A,Lester W,Stuart SP,et al.Risk of depression and other mental health disorders in women with polycystic ovary syndrome:a longitudinal study.Fertil Steril,2009,91:207-212.
23 Deeks AA,Gibson-Helm ME,Paul E,et al.Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression.Hum Reprod,2011,26:1399-1407.
24 Gur E B,Gokduman A,Turan GA,et al.Mid-pregnancy vitamin D levels and postpartum depression.Eur J Obstet Gyn R B,2014,179:110-116.
25 Yue W,Xiang L,Zhang YJ,et al.Association of serum 25-hydroxyvitamin D with symptoms of depression after 6 months in stroke patients.Neurochem Res,2014,39:2218-2224.
26 王波.维生素D抗多囊卵巢综合征合并抑郁患者免疫过激的效果.实用临床医药杂志,2016,20:210-212.
27 Merhi Z,Irani M,Doswell AD,et al.Follicular fluid soluble receptor for advanced glycation end-products (sRAGE):a potential indicator of ovarian reserve.J Clin Endocr Metab,2013,99(2):E226-E233.
28 Hathcock JN,Shao A,Vieth R,et al.Risk assessment for vitamin D.Am J Clin Nutr,2007,85:6-18.
29 廖祥鹏,张增利,张红红,等.维生素D与成年人骨骼健康应用指南(2014年标准版).中国骨质疏松杂志,2014,20:1011-1030.
30 Vieth R.The pharmacology of vitamin D,including fortification strategies.Vitamin D,2005,2:995-1015.
31 Whiting SJ,Calvo MS.Correcting poor vitamin D status:do older adults need higher repletion doses of vitamin D3 than younger adults.Mol Nutr Food Res,2010,54:1077-1084.
32 Dravecká I,Figurova J,Javorsky′ M,et al.The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome-a preliminary study.Physiol Res,2016,65:815.